<p>Herceptin, one of the first targeted cancer therapies, started with the discovery of a new gene with unexpectedly higher expression in breast cancer cells compared to healthy ones. This discovery led scientists to a new antibody that slowed breast cancer progression and extended survival in clinical trials. Herceptin has turned human epidermal growth factor receptor 2 (HER2)-positive breast cancer into one of the most treatable breast cancer forms.&nbsp;</p><p><strong>Download this milestone article from <em>Drug Discovery News</em> to learn about Herceptin's development and how it revolutionized cancer treatment.</strong></p>

Top view of a breast tumor that might be treatable with the monoclonal antibody herceptin

61327-science-milestone-herceptin-ppl-banners-elk-800-x-560-istock-image-only

september-front-cover

September 2023

untitled-design-17

Herceptin transformed breast cancer treatment and opened the door to targeted therapy.&nbsp;

Cancer

Immunology

Science Milestone: The rise of Herceptin

Article

Milestones

1-0325-cover

March 2025

Danielle Gerhard, PhD

Research Areas

Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

1800x900-1

Thermo Fisher Scientific

Discover how better sample preparation can unlock improved assay accuracy and analytical results.

The crucial role of sample preparation in biotherapy manufacturing

Webinars

A black mosquito is shown on pink human skin against a blurred green backdrop. 

istock-2155777642-1800x900

embrient-formerly-bri-v-mid-l

Embrient

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite&rsquo;s complex lifecycle and global burden.

Discovering deeper insights into malaria research

Posters

Three burgundy round and linear conformations of oligonucleotides are shown against a black background. 

istock-2152537301-1800x900

cn-bio-logo-colour-300mm

CN Bio

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Application Note

Herceptin transformed breast cancer treatment and opened the door to targeted therapy.